Many Patients Cycle On and Off GLP-1 Obesity and Diabetes Medications

A significant number of individuals who start GLP-1 medicines for obesity and diabetes later quit them but plan to restart, a practice not currently recommended due to unknown long-term health impacts.

15 Apr, 09:00 — 15 Apr, 09:00

Post Share

Sources

Showing 1 of 1 sources

NPRHigh9d ago

Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it

A majority of people who start the obesity and diabetes medicines known as GLP-1s also quit them, and plan to restart again. Research hasn't yet shown the health impacts of cycling on and off the drugs.

By Yuki Noguchi

Read full article →

PERSPECTA

PERSPECTA

Many Patients Cycle On and Off GLP-1 Obesity and Diabetes Medications

Sources

Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

Bukidnon Hosts Regional Innovation Exhibit

Philippine DOE Considers Lifting Coal Plant Moratorium Amid Concerns

Police Official Implicated as P784-M Counterfeit Cigarettes Seized in Negros Occidental

PERSPECTA